Search
for
Sort by
Research 30 of 81
- A distinct cutaneous reaction to sorafenib and a multikinase inhibitor
- Acne inversa-like lesions associated with the multi-kinase inhibitor sorafenib
- Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Cutaneous adverse effects of targeted therapies
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- Sorafenib-Associated Facial Acneiform Eruption
- Case of alopecia induced by sorafenib, possible mechanism similar to alopecia areata
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Sorafenib-induced Facial Acneiform Eruption
- Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Dermatologic Adverse Events from Cancer Treatments
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- An overview of management of drug-induced hair and nail disorders
- Cancer Treatments and Alopecia: A Systematic Review
- Management of Toxicities of Targeted Therapies
- Cutaneous drug reactions
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib